Strategic AI launches Longeviti recently announced ClearFit AI and Brain Ultrasound Interface (BUI) to advance platform solutions for neurological disorders, signaling a technology-forward posture and potential for cross-sell of advanced imaging capabilities to neuroscience clinics and hospitals.

Clinical partnerships Historical collaboration with Johns Hopkins and ongoing engagement with Clarius Mobile Health suggest a receptive ecosystem for expanding integrative solutions, creating opportunities to pilot or deploy the ClearFit platform within major academic medical centers and imaging workflows.

Board and leadership signals New board appointments including a former Stryker executive and a T. Rowe Price CEO bring strategic governance and influential network access, which can facilitate introductions to large hospital systems and potential integrator collaborations.

Growth and ops signals Revenue range and a mid-size employee base indicate a scaling company likely open to channel partnerships, distribution agreements, and OEM-style collaborations to extend market reach and production capacity.

Expansion opportunities Recent market-facing activities such as attendance at skull base meetings and distributor relationships with Clarius position Longeviti to expand into neuroimaging centers, neurosurgery groups, and trauma centers seeking real-time post-surgical imaging solutions.